Monoclonal antibodies to superficial papillary bladder tumor cells

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5039611
SERIAL NO

07102170

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There is provided four distinct hybrid cell lines bearing numbers M75, M300, M344 and 19A211, each producing a different monoclonal antibody of class lgG1, each antibody when used alone or in combination with one or more of the other three antibodies being capable of selective binding with one or more distinct antigens produced by superficial papillary bladder tumors of the human urinary bladder. There is also provided a method for producing such cell lines as well as a method and a test kit for the detection of distinct antigens produced by superficial papillary bladder turmors of the human urinary bladder. Provision is also made for use in flow cytometry (single or multiple laer) and in biosensors for detect of these antigens.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE LAVAL CITE UNIVERSITAIREQUEBEC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fradet, Yves Sillery, CA 21 125

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation